Atea Pharmaceuticals

(NASDAQ) AVIR

Current Price$4.68

Market Cap$373.73M

Since IPO (2020)-85%

5 Year-77%

1 Year+58%

1 Month-14%

Atea Pharmaceuticals Financials at a Glance

Market Cap

$373.73M

Revenue (TTM)

$0.00

Net Income (TTM)

-$169.52M

EPS (TTM)

-$2.12

P/E Ratio

-2.20

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$4.68

Volume

9,918

Open

$4.67

Price

$4.68

Volume

9,918

Open

$4.67

Previous Close

$4.68

Daily Range

$4.60 - $4.74

52-Week Range

$2.78 - $6.45

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$4.68

Volume

9,918

Open

$4.67

Previous Close

$4.68

Daily Range

$4.60 - $4.74

52-Week Range

$2.78 - $6.45

AVIR News

Page 1

AVIR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Atea Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Jean-Pierre Sommadossi, PhD

Website

www.ateapharma.com

Headquarters

Boston, MA 02110, US

AVIR Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-53%

Return on Capital

-81%

Return on Assets

-63%

Earnings Yield

-45.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$373.73M

Shares Outstanding

80.03M

Volume

9.92K

Avg. Volume

442.55K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$180.89M

EBITDA

-$180.47M

Operating Cash Flow

-$132.03M

Capital Expenditure

$0.00

Free Cash Flow

-$132.03M

Cash & ST Invst.

$301.83M

Total Debt

$843.00K

Atea Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$104.00K

+97.0%

Gross Margin

0.00%

N/A

Market Cap

$373.73M

N/A

Market Cap/Employee

$6.67M

N/A

Employees

N/A

Net Income

-$45.44M

-32.6%

EBITDA

-$47.90M

-23.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$255.37M

-39.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$634.00K

-21.8%

Return on Assets

-63.47%

N/A

Return on Invested Capital

-81.24%

N/A

Free Cash Flow

-$46.39M

-51.8%

Operating Cash Flow

-$46.39M

-51.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VNDAVanda Pharmaceuticals Inc.

VNDAVanda Pharmaceuticals Inc.$6.45-2.86%

ENTAEnanta Pharmaceuticals, Inc.

ENTAEnanta Pharmaceuticals, Inc.$13.16-0.53%

TRDAEntrada Therapeutics, Inc.

TRDAEntrada Therapeutics, Inc.$7.07+3.67%

VYGRVoyager Therapeutics, Inc.

VYGRVoyager Therapeutics, Inc.$3.87-0.77%

ARCTArcturus Therapeutics Holdings Inc.

ARCTArcturus Therapeutics Holdings Inc.$7.92+0.00%

HUMAHumacyte, Inc.

HUMAHumacyte, Inc.$1.30+1.56%

ALLOAllogene Therapeutics, Inc.

ALLOAllogene Therapeutics, Inc.$2.17-3.56%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCEVirgin Galactic

SPCEVirgin Galactic$6.18+0.36%

SOFISoFi Technologies

SOFISoFi Technologies$18.22+0.07%

ONDSOndas

ONDSOndas$13.22-0.00%

BBAIBigBear.ai

BBAIBigBear.ai$5.04+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$46.09+0.12%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.64-0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.92-0.03%

Questions About AVIR

What is the current price of Atea Pharmaceuticals?

Atea Pharmaceuticals is trading at $4.68 per share.

What is the 52-week range for Atea Pharmaceuticals?

Over the past 52 weeks, Atea Pharmaceuticals has traded between $2.78 and $6.45.

How much debt does Atea Pharmaceuticals have?

As of the most recent reporting period, Atea Pharmaceuticals reported total debt of $634.00K.

How much cash does Atea Pharmaceuticals have on hand?

Atea Pharmaceuticals reported $79.32M in cash and cash equivalents in its most recent financial results.

What is Atea Pharmaceuticals’s dividend yield?

Atea Pharmaceuticals does not currently have a dividend yield.

Atea Pharmaceuticals

Atea Pharmaceuticals Financials at a Glance

AVIR News

Atea (AVIR) Q2 Loss Narrows 8%

Why Atea Pharmaceuticals Stock Is Sinking Today

Is There Any Hope for Atea Pharmaceuticals Stock?

How Atea's Clinical Flop Shakes Up the COVID-19 Pill Market

Was Atea Pharmaceutical's Flop Predictable?

Why Atea Pharmaceuticals Stock Got Crushed This Week

Why Atea Pharmaceuticals Is Imploding Today

3 Stocks to Consider if the October Stock Market Sell-Off Worsens

AVIR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Atea Pharmaceuticals

AVIR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Atea Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AVIR

What is the current price of Atea Pharmaceuticals?

What is the 52-week range for Atea Pharmaceuticals?

How much debt does Atea Pharmaceuticals have?

How much cash does Atea Pharmaceuticals have on hand?

What is Atea Pharmaceuticals’s dividend yield?

Premium Investing Services